Skip to main content

Gutartige Nierentumoren

  • Chapter
Nierentumoren
  • 30 Accesses

Zusammenfassung

Gutartige Nierentumoren sind selten. Histopathologisch handelt es sich hierbei um

  1. 1.

    mesenchymale Tumoren wie Fibrome, Myome und Lipome,

  2. 2.

    das epitheliale Adenom und

  3. 3.

    Mischtumoren, z. B. Angiomyolipom.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bell ET (1950) Renal disease. Lea & Febiger, Philadelphia.

    Google Scholar 

  • Bennington JL, Beckwith JB (1975) Tumors of the kidney, renal pelvis and ureter. In: Armed Forces Institute of Pathology, Washington (DC) (ed) Atlas of tumor pathology, vol 12.

    Google Scholar 

  • Colvin RB, Dickersin GR (1978) Pathology of renal tumors. In: Skinner DG, de Kernion JB (eds) Genitourinary cancer. WB Saunders, Philadelphia, pp 84–94.

    Google Scholar 

  • Fryer AE, Chalmers A, Connor JM et al. (1987) Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet I:659–661.

    Article  Google Scholar 

  • Germino GG, Weinstat-Saslow D, Himmelbauer H et al. (1992) The gene for autosomal dominant polycystic kidney disease lies in a 750-kb CpG-rich region. Genomics 13:144–151.

    Article  PubMed  CAS  Google Scholar 

  • Kandt RS, Haines L, Smith M et al. (1992) Linkage of an important gene locus for tuberous sclerosis to a chromomosme 16 marker for polycystic kidney disease. Nat Gen 2:37–41.

    Article  CAS  Google Scholar 

  • Klinger ME (1951) Secondary tumors of the urinary tract. J Urol 65:144.

    PubMed  CAS  Google Scholar 

  • Lang EK (1973) Roentgenographic assessment of asymptomatic renal lesions. Radiology 109:257.

    PubMed  CAS  Google Scholar 

  • Lieber MM (1990) Renal oncocytoma: Prognosis and treatment. J Urol 18 [Suppl 2]:17–24.

    Google Scholar 

  • Murphy GP, Mostofi FK (1970) Histologic assessment and clinical prognosis of renal adenoma. J Urol 103:31.

    PubMed  CAS  Google Scholar 

  • Nogueira E, Bannasch P (1988) Cellular origin of rat renal oncocytoma. Lab Invest 59:337–347.

    PubMed  CAS  Google Scholar 

  • Oesterling JE, Fishman EK, Goldman SM, Marshall F (1986) The management of renal angiomyolipoma. J Urol 135:1121–1125.

    PubMed  CAS  Google Scholar 

  • Stillwell TJ, Gomez MR, Kelalis PP (1987) Renal lesions in tuberous sclerosis. J Urol 138:477–479.

    PubMed  CAS  Google Scholar 

  • Taylor RS, Joseph DB, Kohaut EC, Wilson ER, Bueschen AJ (1989) Renal angiomyolipoma associated with lymph node involvement and renal cell carcinoma in patients with tuberous sclerosis J Urol 141:930–932.

    CAS  Google Scholar 

  • Walt JD van der, Reid HA, Rigdon RA, Shaw JH (1983) Renal oncocytoma: A review of the literature and report of an unusual multicentric case. Virchows Arch [A] 398:291–294.

    Article  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pomer, S. (1977). Gutartige Nierentumoren. In: Nierentumoren. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60332-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60332-7_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64357-6

  • Online ISBN: 978-3-642-60332-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics